Showing results (1821-1830 of 2,090) with videos related to

Sort By:
Pageof 209
Heart Rhythm|November 12, 2021
Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiogramsRemco de Brouwer, Laura M G Meems, Tom E Verstraelen, et al.
The Journal of Molecular Diagnostics : JMD|July 19, 2023
EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART AlgorithmMichiel van den Brand, Markus Möbs, Franziska Otto, et al.
American Journal of Obstetrics and Gynecology|March 18, 2014
Can differences in obstetric outcomes be explained by differences in the care provided? The MFMU Network APEX studyWilliam A Grobman, Jennifer L Bailit, Madeline Murguia Rice, et al.
Journal of Pediatric Ophthalmology and Strabismus|September 21, 2020
Development of Screening Criteria for Retinopathy of Prematurity in Ulaanbaatar, Mongolia, Using a Web-based Data Management SystemShelbi L Olson, Tsengelmaa Chuluunbat, Emily D Cole, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|August 1, 2017
Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathyWouter P Te Rijdt, Z Joy van der Klooster, Edgar T Hoorntje, et al.
The New Phytologist|July 28, 2015
Endemic Mimosa species from Mexico prefer alphaproteobacterial rhizobial symbiontsCyril Bontemps, Marco Antonio Rogel, Anja Wiechmann, et al.
Journal of Cardiovascular Electrophysiology|December 3, 2024
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and ManagementSteven A Muller, Giorgia Bertoli, Jianan Wang, et al.
Circulation. Arrhythmia and Electrophysiology|January 28, 2022
Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular CardiomyopathyLaurens P Bosman, Weijia Wang, Øyvind H Lie, et al.
Nature Communications|September 13, 2019
In vivo epigenetic editing of Sema6a promoter reverses transcallosal dysconnectivity caused by C11orf46/Arl14ep risk geneCyril J Peter, Atsushi Saito, Yuto Hasegawa, et al.
Journal of the American College of Cardiology|November 26, 2011
Mortality risk of untreated myosin-binding protein C-related hypertrophic cardiomyopathy: insight into the natural historyEline A Nannenberg, Michelle Michels, Imke Christiaans, et al.
Pageof 209